Legal Opinion
Prometheus Laboratories, Inc. v. Roxane Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided November 10, 2015No. 2014-1634, 2014-1635PublishedCited by 17 opinions
1Opinion of the Court
DYK, Circuit Judge.
Prometheus Laboratories, Inc. (“Prometheus”) appeals a judgment of the U.S. District Court for the District of New Jersey holding the amended claims of U.S. Patent No. 6,284,770 (“the '770 patent”) invalid. The district court, found the claims would have been obvious over the prior art or, in the alternative, invalid on grounds of obviousness-type double patenting over U.S. Patent No. 5,360,800 (“the '800 patent”). We affirm the district court’s decision because the claims of the '770 patent are invalid as obvious over the '800 patent and other prior art, and do not reach…
2Cases cited10 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
5 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Eli Lilly and Company v. Teva Parenteral MedicinesCourt of Appeals for the Federal Circuit · 2017
- Zup, LLC v. Nash Manufacturing, Inc.Court of Appeals for the Federal Circuit · 2018
- Pernix Ir. Pain Dac v. Alvogen Malta Operations Ltd.District Court, D. Delaware · 2018
- American Innotek, Inc. v. United StatesUnited States Court of Federal Claims · 2016
- Hospira, Inc. v. Amneal Pharm., LLCDistrict Court, D. Delaware · 2018
12 more not listed; retrieve them via the Exa API.